Covid-19 Situation in Europe
WHO warns Europe once again at epicentre of pandemic. The WHO Regional Office for Europe issued a statement on the 23rd, stating that the average daily number of COVID-19 deaths in the European region in the past week was close to 4,200, which was double the figure at the end of September. So far, the cumulative number of deaths from the COVID-19 in 53 countries in the region has exceeded 1.5 million.
WHO/Europe believes that the main reasons for the current epidemic situation in the region include: the highly infectious Delta strain has become the main virus spreading in the region; some countries believe that the COVID-19 epidemic is no longer an "emergency threat". The "mask order" and the maintenance of social distancing and other epidemic prevention measures have been lifted; as the weather becomes colder, people are spending more time indoors; many people have not yet been vaccinated, and vaccine effectiveness against infection gradually declines over time.

The Shortage of Testing and the Advantages of Antigen Tests
Many European countries are now grappling with shortages of coronavirus-testing as the daily coronavirus cases keep rising and hit record high. While PCR testing capacity is limited, rapid antigen detection tests are now widely used across Europe.
Compared with PCR, antigen tests can provide rapid and reliable result in just 15 minutes. Rapid antigen tests can greatly reduce transmission through early detection of highly infectious cases, pre-symptomatic and early symptomatic cases up to five days from symptom onset and help with isolation and contact tracing.
For antigen tests, you don’t need to go to a clinic or wait days for results. Just go to a local pharmacy whenever you want, swab your nose and read result in 15 minutes.
Antigen Test is Now Valid Proof for Entering Europe
Europe is now cautiously opening its border. Requiring travellers to present a negative COVID-19 test result is now the most normal thing when entering European countries as every country is trying to control the pandemic and protect their people.
Belgium is one of the European Union Member States that just recently announced that the country now accepts rapid antigen tests as valid proof for entry. A lot of popular EU destinations including Germany, Switzerland, Czechia, Poland, France, Netherlands, Portugal, Spain, Italy, Iceland and Greece also accept rapid antigen tests.
However, the validity of test result differs in different countries.
What Singclean is Doing Now?

Singclean is now ramp up production to over 6 million per week to meet rising demand of antigen testing worldwide. Our CE approved antigen tests including self-testing nasal swab, antigen swab, nasopharyngeal swab are being exported to many places which are hardest hit by Coronavirus, like Germany, Czech Republic, Lithuania, Greece and Thailand to aid in the early diagnosis of COVID-19 and help stop Covid-19 transmission rapidly.
We want to contribute to the fight against Covid-19 pandemic and we are doing it right now! Broader availability of rapid antigen test, together with high vaccination rates to establish herd immunity, could help end the pandemic soon.
-
singclean | 2021-11-26
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2021-11-26
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2021-11-26
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling